Literature DB >> 23073977

Sensitization to skin-associated microorganisms in adult patients with atopic dermatitis is of importance for disease severity.

Andreas Sonesson1, Jacek Bartosik, Julie Christiansen, Ingrid Roscher, Fredrik Nilsson, Artur Schmidtchen, Ove Bäck.   

Abstract

Atopic dermatitis (AD) is a chronic inflammatory skin disease. Environmental and genetic factors, as well as microbial products from yeasts and bacteria, play a role in triggering the disease. A cohort of 619 adult patients with AD was screened for severity of AD, sensitization to Malassezia sympodialis, Candida albicans, Staphylococcus aureus enterotoxins and Dermatophagoides pteronyssinus. Serum levels of interleukin (IL)-18 were measured. Immunoglobulin E (IgE) sensitization to the combination of both yeast and mite antigens was found to be associated with more severe disease and higher levels of total IgE. AD patients with IgE sensitization to several microbial antigens had more severe disease than those with no IgE sensitization to microbial antigens. Sera from patients with IgE-associated AD showed higher levels of IL-18. Skin-associated microorganisms are exogenous factors triggering IgE-response and severity of AD. These findings are clinically important, and sensitization to these organisms should be assessed and considered in treatment strategies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23073977     DOI: 10.2340/00015555-1465

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  9 in total

1.  [Adaptive immune response and associated trigger factors in atopic dermatitis].

Authors:  A Heratizadeh; T Werfel; L M Rösner
Journal:  Hautarzt       Date:  2015-02       Impact factor: 0.751

2.  Exposure of Keratinocytes to Candida Albicans in the Context of Atopic Milieu Induces Changes in the Surface Glycosylation Pattern of Small Extracellular Vesicles to Enhance Their Propensity to Interact With Inhibitory Siglec Receptors.

Authors:  Adrian Kobiela; Joanna E Frackowiak; Anna Biernacka; Lilit Hovhannisyan; Aleksandra E Bogucka; Kinga Panek; Argho Aninda Paul; Joanna Lukomska; Xinwen Wang; Eleni Giannoulatou; Aleksandra Krolicka; Jacek Zielinski; Milena Deptula; Michal Pikula; Susanne Gabrielsson; Graham S Ogg; Danuta Gutowska-Owsiak
Journal:  Front Immunol       Date:  2022-06-09       Impact factor: 8.786

Review 3.  The emerging world of the fungal microbiome.

Authors:  Gary B Huffnagle; Mairi C Noverr
Journal:  Trends Microbiol       Date:  2013-05-17       Impact factor: 17.079

Review 4.  Which Way Do We Go? Complex Interactions in Atopic Dermatitis Pathogenesis.

Authors:  Garrett J Patrick; Nathan K Archer; Lloyd S Miller
Journal:  J Invest Dermatol       Date:  2020-09-15       Impact factor: 8.551

Review 5.  The Pathogenetic Effect of Natural and Bacterial Toxins on Atopic Dermatitis.

Authors:  Kyung-Duck Park; Sok Cheon Pak; Kwan-Kyu Park
Journal:  Toxins (Basel)       Date:  2016-12-23       Impact factor: 4.546

Review 6.  Biologics for Treatment of Atopic Dermatitis: Current Status and Future Prospect.

Authors:  Thanaporn Ratchataswan; Tina M Banzon; Jacob P Thyssen; Stephan Weidinger; Emma Guttman-Yassky; Wanda Phipatanakul
Journal:  J Allergy Clin Immunol Pract       Date:  2021-03

7.  Lidocaine inhibits staphylococcal enterotoxin-stimulated activation of peripheral blood mononuclear cells from patients with atopic dermatitis.

Authors:  Qingqing Jiao; Honglin Wang; Zhenglin Hu; Yin Zhuang; Weiqin Yang; Ming Li; Xia Yu; Jianying Liang; Yifeng Guo; Hui Zhang; Xilan Chen; Ruhong Cheng; Zhirong Yao
Journal:  Arch Dermatol Res       Date:  2013-04-16       Impact factor: 3.017

8.  IgE Sensitization Profiles Differ between Adult Patients with Severe and Moderate Atopic Dermatitis.

Authors:  Irene Mittermann; Gustav Wikberg; Catharina Johansson; Christian Lupinek; Lena Lundeberg; Reto Crameri; Rudolf Valenta; Annika Scheynius
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

9.  Performance of the PROTIA™ Allergy-Q® System in the Detection of Allergen-specific IgE: A Comparison With the ImmunoCAP® System.

Authors:  Jae Hyun Lee; Hye Jung Park; Kyung Hee Park; Kyoung Yong Jeong; Jung Won Park
Journal:  Allergy Asthma Immunol Res       Date:  2015-05-26       Impact factor: 5.764

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.